HER2 GENE MUTATION
Clinical trials for HER2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new HER2 GENE MUTATION trials appear
Sign up with your email to follow new studies for HER2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy shows promise for hard-to-treat bile duct cancer
Disease control OngoingThis study tests a combination of chemotherapy (gemcitabine/cisplatin) plus two targeted drugs (trastuzumab and pembrolizumab) as a first treatment for people with HER2-positive bile duct or gallbladder cancer that cannot be removed by surgery. The goal is to see how well this tr…
Matched conditions: HER2 GENE MUTATION
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
New drug targets Hard-to-Treat HER2 cancers in early trial
Disease control OngoingThis early-stage study tests an experimental drug called BL-M17D1 in 120 adults with advanced solid tumors that have a specific protein (HER2) or a HER2 gene change. The main goals are to check the drug's safety, find the right dose, and see if it shrinks tumors. Participants mus…
Matched conditions: HER2 GENE MUTATION
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 16, 2026 23:47 UTC